Table 3.

Secondary outcome analysis of DASH, SPADI, EQ5D5L, and NRS.

	DR group (n = 55)	CR group (n = 53)	p valuea	Time×group interactionb
DASH				0.040
Baseline	61.50 ± 16.36	57.77 ± 16.03	0.234
6 weeks	43.08 ± 14.53	41.58 ± 13.08	0.575
12 weeks	21.42 ± 10.40	24.88 ± 14.44	0.158
24 weeks	11.08 ± 7.45	14.75 ± 11.75	0.057
Δbaseline-6weeks	−18.41 ± 17.46	−16.18 ± 17.29	0.506
Δbaseline-12weeks	−40.08 ± 16.73	−32.89 ± 20.72	0.050
Δbaseline-24weeks	−50.42 ± 15.87	−43.02 ± 19.28	0.031
SPADI				0.001
Baseline	92.36 ± 10.63	81.31 ± 19.67	0.001
6 weeks	53.31 ± 18.28	50.76 ± 15.29	0.434
12 weeks	26.90 ± 14.11	27.89 ± 15.98	0.734
24 weeks	11.94 ± 10.08	15.18 ± 12.66	0.145
Δbaseline-6weeks	−39.05 ± 21.93	-30.55 ± 18.78	0.033
Δbaseline-12weeks	−65.46 ± 17.12	−53.42 ± 22.87	0.003
Δbaseline-24weeks	−80.42 ± 13.19	−66.13 ± 22.50	<0.001
EQ5D5L				0.016
Baseline	0.479 ± 0.131	0.524 ± 0.157	0.105
6 weeks	0.699 ± 0.107	0.712 ± 0.126	0.567
12 weeks	0.802 ± 0.053	0.769 ± 0.103	0.039
24 weeks	0.833 ± 0.053	0.806 ± 0.091	0.067
Δbaseline-6weeks	0.221 ± 0.151	0.188 ± 0.171	0.297
Δbaseline-12weeks	0.324 ± 0.141	0.245 ± 0.177	0.012
Δbaseline-24weeks	0.354 ± 0.135	0.282 ± 0.166	0.015
NRS				0.878
Baseline	4.87 ± 2.54	5.13 ± 2.88	0.602
6 weeks	4.31 ± 1.97	4.47 ± 1.98	0.670
12 weeks	3.56 ± 1.98	3.53 ± 1.83	0.923
24 weeks	2.35 ± 1.88	2.25 ± 1.80	0.778
Δbaseline-6weeks	−0.56 ± 3.32	−0.66 ± 3.33	0.880
Δbaseline-12weeks	−1.31 ± 3.01	−1.60 ± 3.25	0.626
Δbaseline-24weeks	−2.53 ± 3.04	−2.89 ± 3.08	0.543

DASH Disabilities of Arm, Shoulder and Hand Questionnaire, SPADI Shoulder Pain And Disability Index, EQ5D5L EuroQoL 5-Demension 5-Level questionnaire, NRS Numeric Rating Scale.

^aResults of independent t-test between group comparison.

^bResults of repeated measures ANOVA for group by time effect.